Adherence and viral suppression among infants and young children initiating protease inhibitor-based antiretroviral therapy.

Item

http://www.wikidata.org/entity/Q36759507

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Adherence and viral suppressio ...... -based antiretroviral therapy.

@ast

Adherence and viral suppressio ...... -based antiretroviral therapy.

@en

type

Item

label

Adherence and viral suppressio ...... -based antiretroviral therapy.

@ast

Adherence and viral suppressio ...... -based antiretroviral therapy.

@en

prefLabel

Adherence and viral suppressio ...... -based antiretroviral therapy.

@ast

Adherence and viral suppressio ...... -based antiretroviral therapy.

@en

P1476

Adherence and viral suppressio ...... -based antiretroviral therapy.

@en

P2093

Chloe A Teasdale

http://www.w3.org/2001/XMLSchema#string

Leigh Martens

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple measures reveal antiretroviral adherence successes and challenges in HIV-infected Ugandan children

Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study.

Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects.

Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis.

Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level.

Standard measures are inadequate to monitor pediatric adherence in a resource-limited setting

Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa.

Antiretroviral therapy responses among children attending a large public clinic in Soweto, South Africa.

Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial

Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial.

P304

489-494

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/INF.0B013E31827E84BA

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23249913

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3624073

http://www.w3.org/2001/XMLSchema#string